Tag: Rheumatoid arthritis

Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US

businessnewstoday- September 20, 2021 0

Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg. Ibuprofen and ... Read More

Gilead, Galapagos bag Jyseleca EC approval for rheumatoid arthritis

pharmanewsdaily- September 27, 2020 0

Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and 100 mg tablets) from the European Commission ... Read More

Lilly Covid drug trial : US pharma giant launches phase 3 trial of baricitinib

pharmanewsdaily- June 15, 2020 0

Lilly Covid drug trial : Eli Lilly and Company has enrolled the first patient in a phase 3 randomized, double-blind, placebo-controlled trial to assess the ... Read More

AbbVie reports positive results for RINVOQ in SELECT-CHOICE phase 3 trial

pharmanewsdaily- June 8, 2020 0

AbbVie said that RINVOQ (upadacitinib, 15 mg, once daily) has met the primary endpoint and key secondary endpoints in the SELECT-CHOICE phase 3 trial in ... Read More

Actemra coronavirus clinical trial : Genentech gets FDA nod for COVID-19 trial

pharmanewsdaily- March 24, 2020 0

Actemra coronavirus clinical trial : Genentech has been given approval by the US Food & Drug Administration (FDA) to undertake the phase 3 COVACTA trial ... Read More

Amgen seeks FDA approval for infliximab biosimilar ABP 710

pharmanewsdaily- December 18, 2018 0

Amgen has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for ABP 710, a biosimilar candidate to Johnson & ... Read More

Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU

pharmanewsdaily- July 29, 2018 0

Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the ... Read More